Trials / Active Not Recruiting
Active Not RecruitingNCT06911177
Yeast Mannans and Stool Frequency
Efficacy of Yeast Mannan Supplementation on Increasing Stool Frequency in Generally Healthy Adults: A Randomized Controlled Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Findings from an open-label pilot study of 20 adults suggested that supplementation with 15 g/day of yeast mannans was highly tolerable and demonstrated specific modulation of the microbiota and increased stool frequency in a subset of subjects reporting ≤1 stool per day at baseline. The primary aim of this randomized, double-blind, controlled trial is to determine if yeast mannan supplementation at 12 g/day will increase stool frequency in generally healthy adults reporting ≤1 stool per day. Secondary aims will determine the effect of yeast mannans on intestinal transit time, gastrointestinal symptoms, fecal microbiota composition, and urinary and fecal metabolomics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Yeast mannan | Yeast cell wall fraction of manno-oligosaccharides and mannoproteins supplemented at 12 g/day. |
| DIETARY_SUPPLEMENT | Control (placebo) | A supplement containing yeast protein, yeast extract, and maltodextrin, provided at 12 g/day. |
Timeline
- Start date
- 2025-07-17
- Primary completion
- 2026-03-16
- Completion
- 2026-12-31
- First posted
- 2025-04-04
- Last updated
- 2026-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06911177. Inclusion in this directory is not an endorsement.